Differential <i>O</i> -glucose elongation on a specific EGF repeat within the canonical ligand–binding domain regulates DLL1/4-NOTCH1 signaling
Abstract
Three types of O -linked glycosylation— O -glucose, O -fucose, and O - N -acetylglucosamine— are crucial for the function of Notch receptors, which regulate critical cell fate determination processes in a wide variety of contexts. O -Glucose glycans are transferred to serine residues located between the first and second conserved cysteines within the epidermal growth factor-like (EGF) repeats in the Notch extracellular domain. Previously, O -glucose glycans were shown to be extended to a trisaccharide structure with two xyloses via α1-3 linkages. Our recent studies, however, indicated that the O -glucose glycan on NOTCH1 EGF10 can be extended by hexose and Neu5Ac. Here, we demonstrated that this hexose- and Neu5Ac-extended glycan has a 3’-sialyllactose-like structure synthesized by specific members of two isoenzyme families, B4GALT1 and ST3GAL4. Using mass spectrometry, we identified this modification exclusively on NOTCH1 EGF10 and the analogous NOTCH3 EGF9 domain, with no detection in any other EGF domains in NOTCH1, NOTCH2, and NOTCH3. Sequence comparison and mutagenesis experiments identified one amino acid at position -2 of the fourth cysteine (C 4 -2) in the EGF domain as crucial for the galactose elongation of O -glucose glycans. We further demonstrated that this site-specific elongation of O -glucose on NOTCH1 EGF10 significantly impacts ligand binding and signal transduction of NOTCH1. In the context of early T cell development, the C 4 -2 mutants NOTCH1 A396Y and A396F enhance T cell differentiation through DLL1- and DLL4-dependent NOTCH1 signaling. Our findings contribute to the understanding of the intricate regulatory mechanisms of Notch receptor function mediated by distinct positions and structures of O -glycans.
Article Details
Journal Info
Proceedings of the National Academy of Sciences
National Academy of Sciences
Authors (24)
Yohei Tsukamoto
Department of Molecular Biochemistry, Nagoya University Graduate School of Medicine
Kazuhiro Aoki
Yuichi Kama
Department of Immunology, Tokai University School of Medicine
Hiroyuki Hosokawa
Department of Immunology, Tokai University School of Medicine
Wataru Saiki
Department of Molecular Biochemistry, Nagoya University Graduate School of Medicine
Natsumi Tsukamoto
Department of Molecular Biochemistry, Nagoya University Graduate School of Medicine
Koki Kato
Department of Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka
Yohei Hosokawa
Department of Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka
Rie Sato
Department of Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka
Naoki Uesugi
Department of Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka
Yuki Fujita
Kana Fukazawa
Department of Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka
Daichi Funada
Department of Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka
Fuga Suzuki
Department of Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka
Yuuki Kurebayashi
Department of Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka
Yusuke Urata
Department of Molecular Biochemistry, Nagoya University Graduate School of Medicine
Sae Uchiyama
Department of Molecular Biochemistry, Nagoya University Graduate School of Medicine
Weiwei Wang
Akira Minami
Department of Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka
Tadanobu Takahashi
Department of Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka
Michael Tiemeyer
Complex Carbohydrate Research Center, University of Georgia
Yoshiki Narimatsu
Tetsuya Okajima
Department of Molecular Biochemistry, Nagoya University Graduate School of Medicine
Hideyuki Takeuchi
Department of Molecular Biochemistry, Nagoya University Graduate School of Medicine